Dermapharm Holding SE buy Saftman
Summary
This prediction ended on 15.09.22 with a price of €41.68. The BUY prediction by Saftman for Dermapharm Holding SE performed very badly with a performance of -50.67%. Saftman has 50% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Dermapharm Holding SE | -0.842% | -0.842% | -17.561% |
iShares Core DAX® | -0.612% | 0.567% | 12.585% |
iShares Nasdaq 100 | -3.018% | -3.205% | 26.208% |
iShares Nikkei 225® | -2.647% | 0.330% | 9.482% |
iShares S&P 500 | -1.932% | -1.126% | 23.191% |
Comments by Saftman for this prediction
In the thread Dermapharm Holding SE diskutieren
In the thread Trading Dermapharm Holding SE